Sun Feb 09 12:00:00 UTC 2025: ## Hims & Hers Super Bowl Ad Draws FDA Scrutiny Over Weight-Loss Drug Claims
**New York, NY** – A controversial Super Bowl advertisement for Hims & Hers, a telehealth company, is facing intense criticism for its promotion of weight-loss drugs without adequately disclosing potential risks. The minute-long spot, set to the backdrop of Childish Gambino’s “This is America,” decries the obesity crisis and the high cost of weight-loss treatments, ultimately pitching Hims & Hers’ compounded medications as a “life-changing” solution.
However, the ad has drawn fire for its lack of transparency regarding potential side effects and safety concerns. Senators Richard Durbin (D-IL) and Roger Marshall (R-KS) have written to the FDA, expressing concerns that the advertisement “risks misleading patients” by omitting crucial risk and safety information typically required in pharmaceutical advertising.
The Partnership for Safe Medicines, a coalition of non-profit organizations, echoed these concerns, calling the ad “dangerous” and criticizing the minimal disclosure of the fact that the medications are compounded—meaning they haven’t undergone the standard FDA approval process. The group has urged Fox Corporation to pull the advertisement.
The controversy highlights growing concerns about the marketing of compounded medications and the potential for misleading advertising in the lucrative weight-loss industry. The FDA is now under pressure to investigate the Hims & Hers advertisement and determine whether it violates advertising regulations.
First Piper 